中文
  • 肖松舒
  • Doctoral Degree in Medicine
  • Professor
  • 妇产科副主任
  • 中南大学湘雅三医院
 

Work Experience

  • 2005.7Now

    中南大学湘雅三医院      妇产科

 

Personal Information

Songshu XIAO, M.D.

 

Department of Obstetrics and Gynecology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410008, P. R. China

Tel: 86-731-88618021; Email: xiaosongshu@csu.edu.cn

 


APPOINTMENT

Professor, Obstetrics and Gynecology, 3rd Xiangya Hospital, CSU                       2022-Present

Associate Professor, Obstetrics and Gynecology, 3rd Xiangya Hospital, CSU         2015-2022

Visiting staff, Obstetrics and Gynecology, 3rd Xiangya Hospital, CSU                    2009-2015

Resident, Obstetrics and Gynecology, 3rd Xiangya Hospital, CSU                           2005-2009

 

RESEARCH INTERESTS

Gynecological tumors and specialises in many gynecologic minimally invasive techniques.

 

SELECTED PUBLICATIONS

1.       Yuan J, Xie H, Chen M, Zeng F, Xiao S*.2022. A case report of retroperitoneal ectopic pregnancy with lymphatic migration after in vitro fertilization-embryo transfer: an explanation to embryo distant migration,Fertil Steril, 118(3):598-600. 

2.       Yuan J, Lan H, Huang DQ ,Guo XH ,Liu C,Liu, SP,Zhang P,Cheng, Y*,Xiao S*,2022, Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer, Front Cell Dev Biol, 10, DOI: 10.3389/fcell.2022.852135

3.       Yuan J, Jiang X, Lan H, Zhang X, Ding T, Yang F, Zeng D, Yong J, Niu B*, Xiao S*.2022.Multi-Omics analysis of the therapeutic value of MAL2 based on data mining in human cancer.Front Cell Dev Biol.17;9:736649.

4.       Xie H#Wan Y#Yi SZeng FSun XYang YXiao S*. 2022.Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation. Int J Gynecol Obstet, 158(2): 301-307. 

5.       Lan H,Yuan J, Chen X,Liu C,Guo X,Wang X,Song J,Cao K*,Xiao S*. 2021.Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinomaBiosci Rep. 22;41(12): BSR20211719.

6.       Chen X#, Lan H#, He D, Xu R, Zhang Y, Cheng Y,Chen H, Xiao S*, Cao K*.2021.Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis. Front Immunol. 19;12:645839.

7.       Chen X#, Lan H#, He D, Wang Z, Xu R, Yuan J, Xiao M, Zhang Y, Gong L, Xiao S*, Cao K*. 2021.Analysis of autophagy-related signatures identified two distinct subtypes for evaluating the tumor immune microenvironment and predicting prognosis in ovarian cancer.Front Oncol. 10;11:616133.

8.       Lan H ,Yuan J , Zeng D,Liu C , Guo X , Yong J ,Zeng X *, Xiao S*2021.The emerging role of non-coding RNAs in drug resistance of ovarian cancer, Front Gene. 20;12:693259.

9.       Yong J,Guo X,Lan H,Yuan J,Zeng D, Zeng X,Yi S,Xiao S*.2021.Clinical analysis of the MyoSure hysteroscopic tissue removal system of endometrial polyps in women with an intact hymen.BMC Womens Health,21:214.

10.    Jiang X, Yuan J, Dou Y, Zeng D, Xiao S*.2021.Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1/MDM2/p53 Pathway. Int J Med Sci 18(4):1030-1038. 

11.    Tian M , Chen X ,Li L ,Wu H ,Zeng D ,Wang X , Zhang  Y,  Xiao S*, Cheng Y*.2021.Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.Acta Pharmacol Sin,42(7):1180-1189;

12.    Zhang M, Liang L, He J, He Z, Yue C, Jin X, Gao M, Xiao S*, Zhou Y*. 2020.Fra-1 Inhibits Cell Growth and the Warburg Effect in Cervical Cancer Cells via STAT1 Regulation of the p53 Signaling Pathway. Front Cell Dev Biol. 8:579629.

13.    Dou YZeng DZou ZWan YXu DXiao S*.2020.Hysteroscopic treatment of cesarean scar defect. Arch Gynecol Obstet. ,302(5):1215-1220.

14.    Zeng X , Yuan J, Wang C ,  Zeng D,Yong J , Jiang X,  Lan H,Xiao S*.2020.circCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate BRD4 signals.Mol Med, 26(1):70.

15.    Yuan J, Lan H, Jiang X, Zeng D,Xiao S*.2020.Bcl‑2 family: Novel insight into individualized therapy for ovarian cancer .Int J Mol Med, 46(4):1255-1265.

16.    Zhao C, She X, Zhang Y, Liu C, Li P, Chen S, Sai B, Li Y, Feng J, Liu J, Sun Y, Xiao S*, Li L*,Wu M*. 2020.LRRC4 Suppresses E-Cadherin- Dependent Collective Cell Invasion and Metastasis in Epithelial Ovarian Cancer. Front. Oncol. 10:144.

17.    Dou Y, Huang D, Zeng X, Zhou Y, Jiang X, Yue C, He J, Xiao S*.2020.All-trans retinoic acid enhances the effect of Fra-1 to inhibit 3 cell proliferation and metabolism in cervical cancer.Biotechnol Lett., DOI 10.1007/s10529-020-02847-8.

18.    Jiang X, Xie H, Dou Y, Yuan J, Zeng D, Xiao S*.2020.Expression and function of FRA1 protein in tumors, Molecular Biology Reports, 47(1):737-752.

19.    Xiao S, Li Y ,Pan Q, Ye M, He S, Tian Q, Xue M*. 2019. MiR-34c /SOX9 axis regulates the chemo-resistance of ovarian cancer cell to cisplatin (DDP)-based chemotherapy.J Cell Biochem, 120(3):2940-2953.

20.    Zeng X, Jiang X,Yuan J ,Yong J ,Zeng D ,Dou Y,Xie H ,Xiao S*. 2019.lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.Cancer Medicine.  8(16):7074-7085.

21.    Lazare C#, Xiao S#, Meng Y, Wang C, Li W, Wang Y, Chen G, Wei J, Hu J, Xue M* ,Wu P*,2019.Evaluation of Cervical Intraepithelial Neoplasia Occurrence Following the Recorded Onset of Persistent High-Risk Human Papillomavirus Infection: A Retrospective Study on Infection Duration. Front. Oncol.,9:976.

22.    Xiao S,Xie H,Zhu X,Li X,Yi S,Deng X,Xue M*.2019.Study on the Significance of Folate Receptor-Mediated Staining Solution (FRD) Staining in Screening High Grade Cervical Lesions.Med Sci Monit. 16;25:2792-2801.

23.    Zeng X,Xie H ,Yuan J , Jiang X,Yong J ,Zeng D ,Dou Y,Xiao S*.  2019.M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.Cancer Biol Ther.20(7):956-966.

24.    Dou Y, Jiang X, Xie H, He J, Xiao S*.2019.The Jun N-terminal kinases signaling pathway plays a“seesaw”role in ovarian carcinomaA molecular aspect.J Ovarian Res.12:99.

 

25.    Wu H, Xiao J, Xiao S*, Cheng Y*.2019.KRAS: A promising therapeutic target for cancer treatment.Curr Top Med Chem.19(23): 2081-2097.

 

26.    Xiao S, Li Y ,Pan Q, Ye M, He S, Tian Q, Xue M*. MiR-34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin (DDP)-based chemotherapy. J Cell Biochem, 2018 Dec 9.doi:10.1002/jcb.26865.

 

27.    Xiao S, Zhou Y, Yi W, Luo G, Jiang B, Tian Q, Li Y, Xue M*. 2015. Fra‑1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro. Int J Oncol, 46(4): 1677-1684.

 

28.    Xiao S, Fan J, He S, Li Y, Wang L, Yu K, Deng X, Xue M*. 2016. Analysis of human papillomavirus infection in 16,320 patients from a gynecology clinic in Central South China. J Low Genit Tract Dis, 20(4): 327-331.

 

29.    Xiao S, Mu Q, Wan Y, Xue M*. 2016. Spontaneous renal hemorrhage caused by invasive mole: A case report. Eur J Gynaecol Oncol, 37(3): 417-419.

 

30.    Xiao S, Zhou Y, Jiang J, Yuan L, Xue M*. 2014. CD44 affects the expression level of FOSlike antigen 1 in cervical cancer tissues. Mol Med Rep, 9(5): 1667-1674.

 

31.    Xiao S, Wan Y, Xue M*, Zeng X, Xiao F, Xu D, Yang XZhang P, Sheng W, Xu J, Zhou S. 2014. Etiology, treatment, and reproductive prognosis of women with moderate-to-severe intrauterine adhesions. Int J Gynecol Obstet, 125(2): 121-124.

 

32.    Xiao S, Liao S, Zhou Y, Jiang B, Li Y, Xue M*. 2014. High expression of octamer transcription factor 1 in cervical cancer. Oncol Lett, 7(6): 1889-1894.

 

33.    Sun X, Xue M, Xiao S*, Wan Y, Wang B. 2010. Uterine diverticulum complicating pregnancy diagnosed by ultrasound and uteroscopy. Int J Gynecol Obstet, 109: 247-248.

 

34.    Xiao S, Xue M*, Wan Y, Su Z. 2011. Gynandroblastoma with the symptoms of infertility and secondary amenorrhea:one case report. Clin Exp Obstet Gynecol, 38(4): 419-420.

 

35.   Xiao S, Tian Q, Xue M*. 2014. Infertility caused by intrauterine fetal bone retention: A case report. J Med Case Rep, 8: 177.

 

36.    Xiao S, Xue M*, Wan Y, Xu D. 2014. Hysteroscopy- and laparoscopy-based diagnosis and treatment of girls with unbroken hymen with an obstructing uterine septum: two case reports. J Med Case Rep, 8: 222.

 

37.    Xiao S, Xue M*, Deng X, Wan Y. 2011. Occurrence of multiple Mullerian adenocele inside the uterine body. J Gynecol Surg, 27(1): 43-44.

 

38.    Xiao S, Lei R, Xue M*. 2013. Primary teratoma in preperitoneal space: Case report and literature review. J Gynecol Surg, 29(5): 248-250.

 

39.    Guan Y, Jiang S, Yu P, Wen M, Zhang Y, Xiao S*, Xu X*, Cheng Y*. 2018. Suppresion of eEF-2K-mediated autophagy enhances the cytotoxicity of Raddeanin A against human breast cancer cells in vitro. Acta Pharmacol Sin, 39(4): 642-648.

 


  • Professor
    Supervisor of Doctorate Candidates
    Supervisor of Master's Candidates
  • Date of Employment:2005-07-01
  • School/Department:中南大学湘雅三医院
  • Administrative Position:妇产科副主任
  • Education Level:With Certificate of Graduation for Doctorate Study
  • Business Address:Dept. of OBGYN Third Xiangya Hospital of Central South University 138 Tongzipo Rd, Changsha, Hunan, China, 410013
  • Sex:Female
  • Contact Information:xiaosongshu@csu.edu.cn
  • Degree:Doctoral Degree in Medicine
  • Status:Employed
  • Academic Titles:湖南省医学会妇产科专业委员会委员,中国医师协会微无创专业委员会青年委员,中国妇幼保健协会妇幼微创专业委员会宫腔镜学组常务委员,湖南省抗癌协会妇科肿瘤专业委员会青年委员会副主任委员,湖南省妇幼保健与优生优育协会妇女健康促进专业委员会副主任委员中国医师协会微无创专业委员会第一届及第二届青年委员湖南省抗癌协会妇科肿瘤专业委员会青年委员会副主任委员中国人体健康科技促进会妇产科智慧医疗专业委员会委员中国医疗保健国际交流促进会妇产科分会青年委员首届中国研究型医院学会妇科肿瘤专业委员会青年委员中国医师协会妇产科医师分会第三届委员会青年委员会委员中国医师协会微无创医学专业委员会第二届委员会妇科肿瘤
  • Alma Mater:中南大学
  • Discipline:Clinical Medicine
  • Email:
Central South University  All rights reserved  湘ICP备05005659号-1 Click:
  MOBILE Version

The Last Update Time:..